CYTK Stock-Based Compensation
Cytokinetics Inc · Stock-Based Compensation
CYTK Stock-Based Compensation
Latest reported$96.80Mperiod ending
CYTK TTM Stock-Based Comp ($1.32M → $96.80M)
TTM stock-based compensation
High-resolution chart · PNG
CYTK stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 96,801,000 | |
| 88,625,000 | |
| 81,780,000 | |
| 108,030,000 | |
| 102,690,000 | |
| 99,777,000 | |
| 97,840,000 | |
| 91,077,000 | |
| 84,437,000 | |
| 78,483,000 | |
| 56,871,000 | |
| 50,882,000 | |
| 32,166,000 | |
| 25,693,000 | |
| 34,678,000 | |
| 27,891,000 | |
| 35,658,000 | |
| 30,556,000 | |
| 26,832,000 | |
| 24,998,000 | |
| 21,923,000 | |
| 19,357,000 | |
| 17,620,000 | |
| 12,743,000 | |
| 10,834,000 | |
| 9,126,000 | |
| 7,884,000 | |
| 17,645,000 | |
| 17,434,000 | |
| 17,120,000 | |
| 17,241,000 | |
| 9,920,000 | |
| 9,795,000 | |
| 9,509,000 | |
| 9,028,000 | |
| 8,468,000 | |
| 7,887,000 | |
| 7,457,000 | |
| 7,146,000 | |
| 6,614,000 | |
| 5,869,000 | |
| 5,282,000 | |
| 4,567,000 | |
| 4,105,000 | |
| 3,875,000 | |
| 3,532,000 | |
| 3,330,000 | |
| 3,100,000 | |
| 3,054,000 | |
| 3,325,000 | |
| 3,597,000 | |
| 3,848,000 | |
| 4,067,000 | |
| 3,806,000 | |
| 3,783,000 | |
| 3,717,000 | |
| 3,389,000 | |
| 3,251,000 | |
| 3,069,000 | |
| 3,080,000 | |
| 3,503,000 | |
| 3,784,000 | |
| 4,017,000 | |
| 4,337,000 | |
| 4,439,000 | |
| 4,651,000 | |
| 4,906,000 | |
| 9,340,000 | |
| 8,079,000 | |
| 6,855,000 | |
| 6,766,000 | |
| 6,713,000 | |
| 6,713,000 | |
| 6,713,000 | |
| 6,713,000 | |
| 5,803,000 | |
| 5,803,000 | |
| 5,803,000 | |
| 5,581,000 | |
| 2,365,000 | |
| 2,365,000 | |
| 2,365,000 | |
| 1,829,000 | |
| 1,328,000 | |
| 1,328,000 | |
| 1,328,000 | |
| 1,315,000 |